(Date:7/25/2008)...n, can potentially contain a naturally occurring t... public health according to a review paper publish... the Science of Food and Agriculture (JSFA). , ...reen, affected area is enough to eliminate most of...uggests that the levels of GA in potatoes can be c...
(Date:7/24/2008)...pe promise to make it easier for people with impai...ing sharper distance vision. Schepens Eye Research...hese innovative glasses over earlier devices in an...al of Biomedical Optics , mailed in print form to... several advantages," says the inventor of the gla...
(Date:7/24/2008)...the life of a cell, the response to DNA damage det...air itself, commit suicide, or grow uncontrollably...shed in the July 25th issue of Cell , scientists ...y that cells respond to DNA damage through a proce... points to a new pathway for the development of ca...
(Date:7/24/2008)...Proteins (NSP), a new family of genes discovered b...esearch and Molecular Medicine in Temple Universit...volved in apoptosis or programmed cell death. , ...g, then a doctoral student at the University and n...ersity and the Cardeza Foundation, and Antonio Gio...
Breaking Biology News(10 mins):Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3A new cellular pathway linked to cancer is identified by NYU researchers 2Novel structure proteins could play a role in apoptosis 2PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 883 1PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 883 2PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 883 3PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 883 4NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 881 1NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 881 2NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 881 3NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 881 4NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 881 5NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 881 6NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 881 7The Oral Cancer Foundation Issues First Research Grants 6684 1The Oral Cancer Foundation Issues First Research Grants 6684 2The Oral Cancer Foundation Issues First Research Grants 6684 3Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program 6682 1Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program 6682 2Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program 6682 3Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program 6682 4